Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pradip K. Saha is active.

Publication


Featured researches published by Pradip K. Saha.


American Journal of Respiratory and Critical Care Medicine | 2009

FoxP3+ Regulatory T Cells Suppress Effector T-Cell Function at Pathologic Site in Miliary Tuberculosis

Prabhat K. Sharma; Pradip K. Saha; Amar Singh; Surendra Sharma; Balaram Ghosh; Dipendra K. Mitra

RATIONALE The inadequacy of effector T-cell response in containment of tubercle bacilli is believed to result in the development of disseminated forms of tuberculosis (TB), such as miliary tuberculosis (MTB). Regulatory T cells (Treg) plausibly play a critical role in the immunopathogenesis of disseminated TB by suppression of effector immune response against Mycobacterium tuberculosis at the pathologic site(s). To understand the role of Treg cells in disseminated tuberculosis, we studied the frequency and function of Treg cells derived from the local disease site specimens (LDSS) of patients with TB pleural effusion and MTB as clinical models of contained and disseminated forms of disease, respectively. OBJECTIVES To (1) enumerate the frequency of Treg cells in bronchoalveolar lavage (BAL) fluid of patients with MTB and compare with that of peripheral blood, (2) study the role of Treg cells in suppression of local T-cell response, and (3) study the selective recruitment of Treg cells at the local disease site(s). METHODS Flow cytometry, reverse transcriptase polymerase chain reaction, and 3-(4,5-dimethylthythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)-based cell proliferation assay. MEASUREMENTS AND MAIN RESULTS Frequency of Treg cells (CD4(+)CD25(+)FoxP3(+)) was significantly higher in LDSS in MTB along with higher levels of FoxP3 mRNA. Importantly, FoxP3(+) Treg cells obtained from the BAL of patients with MTB predominantly produced IL-10 and could suppress the autologous T-cell proliferation in response to M. tuberculosis antigen. CONCLUSIONS Our results highlight the importance of Treg cells in suppression of effector immune response and their influence on bacillary dissemination, disease manifestation, and severity.


BMC Infectious Diseases | 2004

Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India

S. K. Sharma; Tamilarasu Kadhiravan; Amit Banga; Tarun Goyal; Indrish Bhatia; Pradip K. Saha

BackgroundLiterature on the spectrum of opportunistic disease in human immunodeficiency virus (HIV)-infected patients from developing countries is sparse. The objective of this study was to document the spectrum and determine the frequency of various opportunistic infections (OIs) and non-infectious opportunistic diseases, in hospitalised HIV-infected patients from north India.MethodsOne hundred and thirty five consecutive, HIV-infected patients (age 34 ± 10 years, females 17%) admitted to a tertiary care hospital in north India, for the evaluation and management of an OI or HIV-related disorder between January 2000 and July 2003, were studied.ResultsFever (71%) and weight loss (65%) were the commonest presenting symptoms. Heterosexual transmission was the commonest mode of HIV-acquisition. Tuberculosis (TB) was the commonest OI (71%) followed by candidiasis (39.3%), Pneumocystis jiroveci pneumonia (PCP) (7.4%), cryptococcal meningitis and cerebral toxoplasmosis (3.7% each). Most of the cases of TB were disseminated (64%). Apart from other well-recognised OIs, two patients had visceral leishmaniasis. Two cases of HIV-associated lymphoma were encountered. CD4+ cell counts were done in 109 patients. Majority of the patients (82.6%) had CD4+ counts <200 cells/μL. Fifty patients (46%) had CD4+ counts <50 cells/μL. Only 50 patients (37%) received antiretroviral therapy. Twenty one patients (16%) died during hospital stay. All but one deaths were due to TB (16 patients; 76%) and PCP (4 patients; 19%).ConclusionsA wide spectrum of disease, including both OIs and non-infectious opportunistic diseases, is seen in hospitalised HIV-infected patients from north India. Tuberculosis remains the most common OI and is the commonest cause of death in these patients.


Scientific Reports | 2017

Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial

Surendra Sharma; Kiran Katoch; Rohit Sarin; Raman Balambal; Nirmal Kumar Jain; Naresh Patel; Kolluri J. R. Murthy; Neeta Singla; Pradip K. Saha; Ashwani Khanna; Urvashi B. Singh; Sanjiv Kumar; A. Sengupta; Jayant Nagesh Banavaliker; Devendra Singh Chauhan; Shailendra Sachan; Mohammad Wasim; Sanjay Tripathi; Nilesh Dutt; Nitin Jain; Nalin Joshi; Sita Ram Raju Penmesta; Sumanlatha Gaddam; Sanjay Gupta; Bakulesh Khamar; Bindu Dey; Dipendra K. Mitra; Sunil K. Arora; Sangeeta Bhaskar; Rajni Rani

Prolonged treatment of tuberculosis (TB) often leads to poor compliance, default and relapse, converting primary TB patients into category II TB (Cat IITB) cases, many of whom may convert to multi-drug resistant TB (MDR-TB). We have evaluated the immunotherapeutic potential of Mycobacterium indicus pranii (MIP) as an adjunct to Anti-Tubercular Treatment (ATT) in Cat II pulmonary TB (PTB) patients in a prospective, randomized, double blind, placebo controlled, multicentric clinical trial. 890 sputum smear positive Cat II PTB patients were randomized to receive either six intra-dermal injections (2 + 4) of heat-killed MIP at a dose of 5 × 108 bacilli or placebo once in 2 weeks for 2 months. Sputum smear and culture examinations were performed at different time points. MIP was safe with no adverse effects. While sputum smear conversion did not show any statistically significant difference, significantly higher number of patients (67.1%) in the MIP group achieved sputum culture conversion at fourth week compared to the placebo (57%) group (p = 0.0002), suggesting a role of MIP in clearance of the bacilli. Since live bacteria are the major contributors for sustained incidence of TB, the potential of MIP in clearance of the bacilli has far reaching implications in controlling the spread of the disease.


Cytokine | 2013

Recruitment of Th1 effector cells in human tuberculosis: Hierarchy of chemokine receptor(s) and their ligands

Pradip K. Saha; Prabhat K. Sharma; Surendra Sharma; Amar Singh; Dipendra K. Mitra

Selective recruitment of IFN-γ biased Th1 effector cells at the pathologic site(s) determines the local immunity of tuberculosis (TB). We observed the enrichment of CXCR3, CCR5 and CD11a(high) T cells in the peripheral blood, pleural fluid and bronchoalveolar lavage of TB pleural effusion (TB-PE) and miliary tuberculosis (MTB) patients respectively. CXCR3(+)CCR5(+) T cells were significantly high at the local disease site(s) in both the forms of TB and their frequency was highest among activated lymphocytes in TB-PE. Interestingly, all CCR5(+) cells were invariably positive for CXCR3 but all CXCR3(+) cells did not co-express CCR5 in pleural fluid whereas the situation was reverse in bronchoalveolar lavage. These CXCR3(+)CCR5(+) cells dominantly produced IFN-γ in response to Mycobacterium tuberculosis antigen. In vitro chemotaxis assay indicates dominant role of RANTES and IP-10 in the selective recruitment of CXCR3(+)CCR5(+)cells at the tubercular pathologic sites.


Sexually Transmitted Infections | 2005

Determinants of hospital mortality of HIV infected patients from north India

S. K. Sharma; Tamilarasu Kadhiravan; Amit Banga; Indrish Bhatia; Tarun Goyal; Pradip K. Saha

A majority of the HIV infected population lives in developing nations. Most patients require hospitalisation for management of opportunistic infections (OIs) sometime during the course of their illness. Locally endemic infections and underlying malnutrition tend to influence the manifestations and course of the disease.1 However, there is paucity of data on pattern of disease and determinants of immediate outcome of such patients from Indian subcontinent.2 We report the determinants of hospital mortality in a cohort of 135 consecutive cases of HIV/AIDS, aged 13 years and above, admitted to the All India Institute of Medical Sciences (AIIMS), New Delhi, during the period of January 2000 through July 2003. These patients had …


American Journal of Respiratory and Critical Care Medicine | 2002

Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment

Surendra Sharma; Arumugam Balamurugan; Pradip K. Saha; Ravindra Mohan Pandey; N. K. Mehra


Infection, Genetics and Evolution | 2003

Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study.

S. K. Sharma; Kiran K. Turaga; Arumugam Balamurugan; Pradip K. Saha; Ravindra Mohan Pandey; N.K. Jain; V.M. Katoch; N. K. Mehra


International Journal of Tuberculosis and Lung Disease | 2006

Predictors of development and outcome in patients with acute respiratory distress syndrome due to tuberculosis

S. K. Sharma; Alladi Mohan; Amit Banga; Pradip K. Saha; Kalpalatha K. Guntupalli


American Journal of Respiratory Cell and Molecular Biology | 2003

Human Leukocyte Antigen-DR Alleles Influence the Clinical Course of Pulmonary Sarcoidosis in Asian Indians

Surendra Sharma; Arumugam Balamurugan; Ravindra Mohan Pandey; Pradip K. Saha; N. K. Mehra


Indian Journal of Medical Research | 2011

Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients

Surendra Sharma; Sanjeev Kumar; Pradip K. Saha; Ninoo George; Shivam Arora; Deepak Gupta; Urvashi B. Singh; Mahmud Hanif; Rp Vashisht

Collaboration


Dive into the Pradip K. Saha's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dipendra K. Mitra

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Prabhat K. Sharma

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

S. K. Sharma

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Amit Banga

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Arumugam Balamurugan

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

N. K. Mehra

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Ravindra Mohan Pandey

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Tamilarasu Kadhiravan

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Amar Singh

All India Institute of Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge